WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial ...
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Checkpoint is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-PD-L1 antibody licensed from the Dana-Farber Cancer Institute, in an ongoing global, ...
In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was approved. The drug, known as ipilimumab or Yervoy, stood apart from standard cancer treatments. It worked by ...
Skin cancers, lung cancers, lymphomas—though these cancers affect different parts of the body, they can all be treated with one of the latest therapies medicine has to offer: checkpoint inhibitors.
The Lodi Police Department will conduct a DUI checkpoint from 7 p.m. Saturday, Oct. 17 to 3 a.m. Sunday, Oct. 18 at an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results